Mark Montebello
Biographic Data
| ID | 5567265 |
|---|---|
| NAME | Mark Montebello |
| GIVEN NAMES | Mark |
| FAMILY NAME | Montebello |
| SIGNATURE | MONTEBELLO M |
| AFFILIATIONS | Sydney Local Health District |
| ORCID | 0000-0002-1776-3974 |
| VERIFIED | Yes |
| TOTAL WORKS | 13 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 13 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on Opioids
What Cues Do Laypeople Use to Detect Alcohol and Cannabis Intoxication
‘ Sasadecc ’—A Unique Model of Collaborative Care Between Government and Non‐Government Health Services for Adolescents With Complex Substance Use Issues
Patient preferences for simplified hepatitis C testing modalities among people at risk of hepatitis C infection in Australia
Findings highlight the importance of offering rapid, staff-assisted HCV testing to improve uptake among at-risk populations
A call for concern
Identifying and responding to fetal alcohol spectrum disorder in child and family health
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs
Results highlight important intersections and disparities in stigmatising experiences among people who inject drugs. Considering these intersections can assist health services provide more inclusive care
Week Retention in Treatment With Extended-Release Subcutaneous Buprenorphine Depot Injections Among People With Opioid Dependence
Indivior
Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016–2019
Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia
Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence
No prominent works on this page.
Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia
Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs
Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016–2019
A call for concern
Identifying and responding to fetal alcohol spectrum disorder in child and family health
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs
Results highlight important intersections and disparities in stigmatising experiences among people who inject drugs. Considering these intersections can assist health services provide more inclusive care
Week Retention in Treatment With Extended-Release Subcutaneous Buprenorphine Depot Injections Among People With Opioid Dependence
Indivior
Patient preferences for simplified hepatitis C testing modalities among people at risk of hepatitis C infection in Australia
Findings highlight the importance of offering rapid, staff-assisted HCV testing to improve uptake among at-risk populations
Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on Opioids
What Cues Do Laypeople Use to Detect Alcohol and Cannabis Intoxication
‘ Sasadecc ’—A Unique Model of Collaborative Care Between Government and Non‐Government Health Services for Adolescents With Complex Substance Use Issues
Medicine (10 works) · HIV, Drug Use, Sexual Risk (6 works) · Psychiatry (6 works) · Internal Medicine (5 works) · Opioid Use Disorder Treatment (5 works) · Substance Abuse Treatment and Outcomes (5 works) · Environmental health (4 works) · Psychology (4 works) · Cannabis (3 works) · Cohort (3 works)